TAZICEF is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Ceftazidime.
| Product ID | 0409-5084_312e4e3a-4c8a-42bc-b62d-d007f6ac0756 |
| NDC | 0409-5084 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TAZICEF |
| Generic Name | Ceftazidime |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2005-12-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA062662 |
| Labeler Name | Hospira, Inc. |
| Substance Name | CEFTAZIDIME |
| Active Ingredient Strength | 2 g/1 |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2005-12-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA062662 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2005-12-16 |
| Marketing End Date | 2016-03-24 |
| Marketing Category | ANDA |
| Application Number | ANDA062662 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1986-03-06 |
| Marketing Category | ANDA |
| Application Number | ANDA062662 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-19 |
| Ingredient | Strength |
|---|---|
| CEFTAZIDIME | 2 g/1 |
| SPL SET ID: | 40d48c5d-650e-461b-a67b-7e65772d1b92 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0409-5082 | TAZICEF | CEFTAZIDIME |
| 0409-5084 | TAZICEF | CEFTAZIDIME |
| 0409-5086 | TAZICEF | CEFTAZIDIME |
| 0409-5092 | TAZICEF | CEFTAZIDIME |
| 0409-5093 | TAZICEF | CEFTAZIDIME |
| 0781-3177 | Ceftazidime | Ceftazidime |
| 0781-3178 | Ceftazidime | Ceftazidime |
| 0781-3179 | Ceftazidime | Ceftazidime |
| 25021-127 | Ceftazidime | ceftazidime |
| 0264-3143 | Ceftazidime and Dextrose | CEFTAZIDIME |
| 0264-3145 | Ceftazidime and Dextrose | CEFTAZIDIME |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TAZICEF 77918467 3837729 Live/Registered |
Hospira, Inc. 2010-01-22 |
![]() TAZICEF 74334058 1783825 Dead/Cancelled |
SmithKline Beecham Corporation 1992-11-23 |
![]() TAZICEF 73489701 1412941 Dead/Cancelled |
SMITHKLINE BECKMAN CORPORATION 1984-07-13 |